Rates of Biochemical Remission Remain Higher in Black Men Compared to White Men After Radical Prostatectomy Despite Similar Trends in Prostate Specific Antigen Induced Stage Migration

Journal of Urology

Volumn 178, Issue 4, 2007, Pages 1271-1276

  Wood, Hadley M ^a   Reuther, Alwyn M ^a   Gilligan, Timothy D ^b   Kupelian, Patrick A ^c   Modlin Jr , Charles S ^a   Klein, Eric A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

^c M D ANDERSON CANCER CENTER ORLANDO   (United States)

Author keywords

African Americans; European continental ancestry group; prostate; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CHI SQUARE TEST; EUROPEAN AMERICAN; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 34548389304     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.05.127     Document Type: Article

References (20)

1. Godley P.A., Schenck A.P., Amamoo M.A., Schoenback V.J., Peacock S., Manning M., et al. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. J Natl Cancer Inst 95 (2003) 1702
2. United States Census 2000. United States Census Bureau. Available at http://www.census.gov/main/www/cen2000.html. Accessed April 15, 2006.
3. Sohayda C.J., Kupelian P.A., Altsman K.A., and Klein E.A. Race as an independent predictor of outcome after treatment for localized prostate cancer. J Urol 162 (1999) 1331
4. Jhaveri F.M., Klein E.A., Kupelian P.A., Zippe C., and Levin H.S. Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration. J Clin Oncol 17 (1999) 3167
5. Ries LA, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L et al: SEER Cancer Statistics Review, 1975-2002. Bethesda, Maryland: National Cancer Institute. Available at http://seer.cancer.gov/csr/1975_2002. Accessed April 15, 2006.
6. Powell I.J., Dey J., Dudley A., Pontes J.E., Cher M.L., Sakr W., et al. Disease-free survival difference between African-Americans and whites after radical prostatectomy for local prostate cancer: a multivariate analysis. Urology 59 (2002) 907
7. Shuch B., Mikhail M., Satagopan J., Lee P., Yee H., Chang C., et al. Racial disparity of Epidermal Growth Factor Receptor expression in prostate cancer. J Clin Oncol 22 (2004) 4725
8. Di Lorenzo G., Tortora G., D'Armiento F.P., De Rosa G., Staibano S., Autorino R., et al. Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen- independence in human prostate cancer. Clin Cancer Res 8 (2002) 3438
9. Paris P.L., Kupelian P.A., Hall J.M., Williams T.L., Levin H., Klein E.A., et al. Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients. Cancer Epidemiol Biomarkers Prev 8 (1999) 901
10. Shekarriz B., Tiguert R., Upadhyay J., Gheiler E., Powell I.J., Pontes J.E., et al. Impact of location and multifocality of positive surgical margins on disease-free survival between African-American and white men. Urology 55 (2000) 899
11. Tarman G.J., Kane C.J., Moul J.W., Thrasher J.B., Foley J.P., Wilhite D., et al. Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology 56 (2000) 1016
12. Moul J.W., Connelly R.R., Lubeck D.P., Bauer J.J., Sun L., Flanders S.C., et al. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases. J Urol 1664 (2001) 1322
13. Iselin C.E., Box J.W., Vollmer R.T., Layfield L.J., Robertson J.E., and Paulson D.F. Surgical control of clinically localized prostate carcinoma is equivalent in African-American and white males. Cancer 83 (1998) 2353
14. Freedland S.H., Amling C.L., Dorey F., Kane C.J., Presti Jr. J.C., Terris M.K., et al. Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Center Hospital (SEARCH) database. Urology 60 (2002) 670
15. Peters N., and Armstrong K. Racial differences in prostate cancer treatment outcomes: a systematic review. Cancer Nurs 28 (2005) 108
16. Underwood III W., Wei J., Rubin M.A., Montie J.E., Resh J., and Sanda M.G. Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity. Urol Oncol Semin Orig Invest 22 (2004) 20
17. Tewari A., Horninger W., Pelzer A.E., Demers R., Crawford E.D., Gamito E.J., et al. Factors contributing to the racial differences in prostate cancer mortality. BJU Int 96 (2005) 1247
18. Cross C.K., Shultz D., Malkowicz S.B., Huang W.C., Whittington R., Tomaszewski J.E., et al. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate. J Clin Oncol 20 (2002) 2863
19. Nielson M.E., Han M., Mangold L., Humphreys E., Walsh P.C., Partin A.W., et al. Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center. J Urol 176 (2006) 515
20. Gilligan R., Wang P.S., Levin R., Kantoff P.W., and Avorn J. Racial differences in screening for prostate cancer in the elderly. Arch Intern Med 164 (2004) 1858